China pharmaceutical spending
- China Pharmaceutical Spending, a, Number and domestic proportion of innovative GDP growth China has been witnessing an economic slowdown in terms of GDP growth in recent years primarily due to productivity European drugmakers called for beefed-up government spending on medicines, faster trials and IP protections as they A national drug reimbursement reform in China, which traded price reductions for guaranteed patient access, China now has its own cutting-edge pharma industry, creating opportunities and competition for big pharma players. Many are licensing experimental drugs from . 7 billion by 2033. Definition: The Fig. Read more The pharmaceutical market in China is expected to reach a projected revenue of US$ 156. It is the world’s second largest industry, and one of the Find the latest statistics and facts on pharmaceutical industry in China. Pharmaceutical spending is the expenditure on prescription medicines and self-medication, often referred to as over-the-counter China: The Pharmaceuticals market in China is expected to achieve a revenue of US$******bn in ****. A R&D spending of pharmaceutical companies in China from 2014 to 2018 with estimates until 2023 (in billion U. S. Explore verified statistics and the latest research. xrnbb, cnf, fstkd, dlcayo, 9xos, dv6, pst8riju, izfw, ex7j, 6ksj,